Editorial: Large-bowel cancer-The current status of treatment.
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D007167:Immunotherapy; D008130:Lomustine / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012673:Semustine / Q000627:therapeutic use; D014481:United States
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D008937:Mitomycins; D012673:Semustine; D008130:Lomustine; D004317:Doxorubicin; D005472:Fluorouracil; D002330:Carmustine